Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica

Sponsor
Ziv Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00516009
Collaborator
(none)
40
1
2
11
3.6

Study Details

Study Description

Brief Summary

Acute low back pain is one of the most common reasons for all physician visits(1). Phospholipase A2 (PLA2), a potent inflammatory mediator, has demonstrated to be released by discs following injury(4). Clinical practice and animal research suggest that lumbar radicular pain is the result of inflammation of the nerve root in the epidural space(5). The study will evaluate the efficacy of intravenous Dexamethasone for acute disc herniation-induced sciatica. 40 patients aged 18 years or older, who will be transferred to the emergency room due to sciatic pain will be blindly randomized to receive Dexamethasone 30 mg IV for 3 days an tapering off, 10 mg daily, or normal saline. 20 patients will be in each group. The patients will continue their standard care during the study period. Follow up will last for 3 months. Mann-Whitney test will be used for parametric correlation, Wilcoxon for numeral and x² for categorial variables. Dexamethasone IV can help physicians in treating patients with acute sciatic pain.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica
Study Start Date :
Aug 1, 2007
Anticipated Study Completion Date :
Jul 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1 TREATMENT GROUP

20 PATIENTS WILL RECEIVE DEXAMETHASONE 30 MG IV 3 DAYS AND 20 AND 10 MG FOR THE OTHER TWO DAYS

Drug: DEXAMETHASONE

Placebo Comparator: 2

20 PATIENTS WILL RECEIVE PLACEBO FOR 5 DAYS

Other: PLACEBO

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients aged 18 years or older presented with acute radicular pain for less than 6 weeks.
    Exclusion Criteria:
    • Patient with acute infection,

    • Psychiatric disorder,

    • Uncontroled diabetes,

    • Uncontrolede hypertension,

    • Severe congestive heart failure,

    • Cauda equina syndrome,

    • Moderate or severe motor deficit,

    • Primary spinal stenosis,

    • Pregnancy.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Neurology Unit - Ziv Mc Safed Israel 13100

    Sponsors and Collaborators

    • Ziv Hospital

    Investigators

    • Principal Investigator: RADI SHAHIEN, MD, Ziv Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00516009
    Other Study ID Numbers:
    • HP-7-247S
    First Posted:
    Aug 14, 2007
    Last Update Posted:
    Aug 14, 2007
    Last Verified:
    Aug 1, 2007

    Study Results

    No Results Posted as of Aug 14, 2007